CAP Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Jul 12, 2019 Pathologists Face Hurdles in Supporting Precision Oncology, Seek Shared Decision Making Premium Jun 22, 2018 ASCO, CAP Update HER2 Breast Cancer Testing Clinical Practice Guidelines Mar 16, 2018 ASCO/CAP ctDNA Report Offers Check on Bold Commercial Claims, RoadMap for Proving Value Premium May 1, 2017 BRAF Proficiency Testing Reporting Adequate But Could Improve, Analysis Finds Dec 16, 2016 New Guidelines Aim to Standardize Interpretation and Reporting of Somatic Cancer Variants Premium Mar 30, 2015 CAP, AMP Among Groups Jointly Issuing Colorectal Cancer Molecular Testing Draft Recommendations Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
